Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis
Hemolytic anemia is a rare but recognized extraintestinal manifestation of IBD, and distinguishing autoimmune hemolytic anemia (AIHA) secondary to IBD from drug-induced immune hemolytic anemia (DIIHA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback